Skip to content

ARISE: After 8 Hours Reperfusion in Ischemic Stroke Embolization

ARISE: After 8 Hours Reperfusion in Ischemic Stroke Embolization

Status
Suspended
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02533778
Acronym
ARISE
Enrollment
25
Registered
2015-08-27
Start date
2015-07-31
Completion date
2018-07-01
Last updated
2017-08-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ischemic Stroke

Brief summary

A prospective pilot study to evaluate the recanalization and safety of mechanical thrombectomy through a cerebral angiogram in patients with stroke symptoms last seen normal between 8 - 24 hours.

Detailed description

Ischemic stroke patients who are 8-24 hrs from symptom onset without prior mechanical or IV thrombolytic treatment and are screen with CT or MR perfusion imaging showing penumbra and infarction not \> 1/3rd the territory.

Interventions

DEVICEmechanical thrombectomy

Mechanical thrombectomy by either Penumbra system, TREVO, or Solitaire retrieval device

Sponsors

Abington Memorial Hospital
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

with control group

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Over 18 years last seen normal between 8 - 24 hours, without prior history of intravenous plasminogen activator (IV t-PA ) or * mechanical thrombectomy Vessels - intracranial vertebral artery, basilar artery, intracranial ICA, ICA terminus bifurcation, MCA M1/M2, or * ACA NIHSS ≥ 7 MRI DWI/PWI or * CTA/P, which demonstrates an area of mismatch ≥ 2/3 rd * Signed informed consent

Exclusion criteria

* creat \>= 2 * NIHSS \< 7 * Baseline mRS \>= 2 * infarct \> 1/3rd MCA territory * competing trials * prior IV or IA treatment

Design outcomes

Primary

MeasureTime frame
Thrombolysis in Cerebral Infarction (TICI) score6 months

Secondary

MeasureTime frame
National Institutes of Health Stroke Scale (NIHSS) score6 months
Montreal Cognitive Assessment (MoCA) tool6 months
Modified Rankin Scale6 months

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026